Skip to main content

and
  1. Article

    Open Access

    Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial

    Most guidelines in the UK, Europe and North America do not recommend organised population-wide screening for prostate cancer. Prostate-specific antigen-based screening can reduce prostate cancer-specific morta...

    Edna Keeney, Sabina Sanghera, Richard M. Martin, Roman Gulati in PharmacoEconomics (2022)

  2. Article

    Open Access

    An observational cohort study of health outcomes and costs associated with early pregnancy assessment units in the UK

    The objective of this study was to assess the impact of consultant presence, volume of patients seen and weekend opening on the health and cost-related outcomes associated with different Early Pregnancy Assess...

    Edna Keeney, Maria Memtsa, Venetia Goodhart, Davor Jurkovic in BMC Health Services Research (2022)

  3. No Access

    Article

    Response to Comment on Delphi Analysis of Relevant Comparators in a Cost-Effectiveness Model of Prostate Cancer Screening

    Edna Keeney, Howard Thom, Emma Turner, Richard M. Martin in PharmacoEconomics (2021)

  4. Article

    Open Access

    Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening

    Challenges can exist when framing the decision question in a cost-effectiveness analysis, particularly when there is disagreement among experts on relevant comparators. Using prostate cancer screening and rece...

    Edna Keeney, Howard Thom, Emma Turner, Richard M. Martin in PharmacoEconomics (2021)

  5. Article

    Open Access

    Correction to: Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities

    The Open Access license, which previously read

    Edna Keeney, Dalia Dawoud, Sofia Dias in PharmacoEconomics (2019)

  6. Article

    Open Access

    Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities

    Clinical trials report severe hypoglycaemic events as the number of patients with at least one event out of the total randomised or number of events for a given total exposure. Different network meta-analysis ...

    Edna Keeney, Dalia Dawoud, Sofia Dias in PharmacoEconomics (2018)